Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review

Zhang, Ai-Xue; Mao, Zhuxin; Wang, Zitong; Wu, Jing; Luo, Nan; Wang, Pei

doi:10.1080/14737167.2023.2189590

Cited by 4 publications

(2 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Comparison of the EQ-5D and SF-6D has shown that these measures have moderate agreement but with the EQ-5D having more ceiling effects and the SF-6D having more floor effects (133,134) . For the same condition, the SF-6D has generally been shown to report lower HUV compared to the EQ-5D (134)(135)(136) .…”

Section: Euroqol Instrumentsmentioning

confidence: 96%

Outcome measures for chronic rhinosinusitis with nasal polyps

Sedaghat,

Campbell,

Douglas

et al. 2024

Rhin

View full text Add to dashboard Cite

Background: With the recent proliferation of novel therapeutics for chronic rhinosinusitis with nasal polyps (CRSwNP), there is an immediate need for comprehensive means to assess CRSwNP disease status as well as to determine treatment efficacy. Outcome measures exist in different forms. Patient-reported outcome measures (PROMs) allow patients to provide direct input about their condition that is not possible to obtain in any other way. Common constructs that are measured using PROMs include quality of life or the burden of disease manifestations (e.g., symptom severity). Outcomes may also include the results of objective diagnostic testing/measurement of clinical signs or measured using psychophysical tests. Biomarkers represent an emerging class of outcome measures for CRSwNP and are chosen to directly reflect the active pathophysiologic processes of CRSwNP in the peripheral blood, sinus/polyp tissues, and sinonasal mucus. Methods: Narrative review of the literature, identifying and describing outcome measures that may be used in the evaluation of CRSwNP and for assessment of treatment responses. Results: In this review, we identify many different outcome measures for CRSwNP that fall under the categories of PROM, objective test, psychophysical test or biomarker. We describe the history of each - including seminal studies - and demonstrate the formal validation, psychometric performance, and limitations of each. Conclusions: PROMs, objective tests, psychophysical tests and biomarkers represent different classes of outcome measures that are complementary means of assessing CRSwNP disease status and treatment efficacy. The choice or interpretation of a CRSwNP outcome measure should be undertaken with full knowledge of its formal validation, psychometric performance, and limitations.

show abstract

Section: Euroqol Instrumentsmentioning

confidence: 96%

Outcome measures for chronic rhinosinusitis with nasal polyps

Sedaghat,

Campbell,

Douglas

et al. 2024

Rhin

View full text Add to dashboard Cite

show abstract

“…So far, 12 countries have established SF-6D value sets [ 15 ]. Similar to the EQ-5D-5L, it has demonstrated strong psychometric performance across multiple health conditions [ 16 – 18 ].…”

Section: Introductionmentioning

confidence: 99%

Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary

Nikl,

Janssen,

Jenei

et al. 2024

PharmacoEconomics

View full text Add to dashboard Cite

Objectives This study aimed to develop population norms for three preference-accompanied measures [EQ-5D-5L, Patient-Reported Outcomes Measurement Information System (PROMIS)-preference scoring system (PROPr) and Short-Form Six-Dimension (SF-6D)] in Hungary. Methods In November 2020, an online cross-sectional survey was conducted among a representative sample of the Hungarian adult general population ( n = 1631). Respondents completed the Hungarian versions of the EQ-5D-5L, PROMIS-29+2 version 2.1 and 36-item Short Form Survey version 1 (SF-36v1). The association of utilities with sociodemographic and health-related characteristics of respondents was analysed using multivariate regressions. Results The proportion of respondents reporting problems ranged from 8 to 44% (self-care to pain/discomfort) on the EQ-5D-5L, 39–94% (physical function to sleep) on PROPr and 38–87% (role limitations to vitality) on the SF-6D. Problems related to physical function, self-care, usual activities/role limitations and pain increased with age, while mental health problems decreased in all three measures. In almost all corresponding domains, respondents indicated the fewest problems on the EQ-5D-5L and the most problems on the SF-6D. The mean EQ-5D-5L, PROPr and SF-6D utilities were 0.900, 0.535 and 0.755, respectively. Female gender (PROPr, SF-6D), a lower level of education (EQ-5D-5L, PROPr), being unemployed or a disability pensioner (EQ-5D-5L), being underweight or obese (SF-6D), lack of physical exercise (all) and polypharmacy (all) were associated with significantly lower utilities. PROPr yielded the lowest and EQ-5D-5L the highest mean utilities in 28 of 30 chronic health conditions. Conclusions This study presents the first set of Hungarian population norms for the EQ-5D-5L, PROPr and SF-6D. Our findings can serve as reference values in clinical trials and observational studies and contribute to the monitoring of population health and the assessment of disease burden in Hungary. Supplementary Information The online version contains supplementary material available at 10.1007/s40273-024-01360-4.

show abstract